Screening for acute ocular toxicity of commercialized products of cartap,an insecticide,and correlation to blood concentrations in rabbits

Cartap is an insecticide known to produce contraction and damage to mouse and rabbit diaphragms, and plays a pivotal role in respiratory paralysis and mortality in rabbits. The aim of this study was conducted to screen for the toxic properties and blood concentrations of commercialized cartap products in New Zealand White (NZW) rabbits. Five granular formulations (GRs) with different concentrations (4, 6, 6.5, 6.66 or 10%) and seven water-soluble powders (SPs, 50%) of commercialized cartap products were chosen to study toxicity following ocular instillation. Furthermore, ocular instillation (5, 12.5, 25 or 50 mg kg^?1) and oral administration (25 mg kg^?1) of the technical material (TC) cartap was also performed to compare blood concentration changes in rabbits. There was no death or eye irritation with all GR products; however, soluble powder (SP) products produced severe toxicity and mortality in rabbits. The blood concentration of TC cartap in rabbits started to increase from 2 min and reached peak levels at 7–9 min after ocular instillation in a dose-related pattern. For comparison of the blood distribution of cartap via different administration routes, oral exposure exhibited a higher absorption of cartap than ocular instillation. It was suggested that the commercialized GR products of cartap were safe but 50% SP products were highly toxic to rabbits following ocular exposure. This study provides valuable data to screen for potential acute toxicity of cartap to farmers and animals in the field.